Cargando…
Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216277/ https://www.ncbi.nlm.nih.gov/pubmed/35754457 http://dx.doi.org/10.1016/j.iotech.2020.06.002 |
| _version_ | 1784731386560643072 |
|---|---|
| author | Zhang, D.X. |
| author_facet | Zhang, D.X. |
| author_sort | Zhang, D.X. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9216277 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92162772022-06-24 Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma Zhang, D.X. Immunooncol Technol Letter to the Editor Elsevier 2020-06-25 /pmc/articles/PMC9216277/ /pubmed/35754457 http://dx.doi.org/10.1016/j.iotech.2020.06.002 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Zhang, D.X. Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma |
| title | Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma |
| title_full | Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma |
| title_fullStr | Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma |
| title_full_unstemmed | Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma |
| title_short | Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma |
| title_sort | atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216277/ https://www.ncbi.nlm.nih.gov/pubmed/35754457 http://dx.doi.org/10.1016/j.iotech.2020.06.002 |
| work_keys_str_mv | AT zhangdx atezolizumabandbevacizumabtherevolutionaryduoasagamechangerinadvancedhepatocellularcarcinoma |